OP-ED: Coronavirus: How a Rational CDC Scientist Would

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
194
OP-ED: Coronavirus: How a Rational CDC Scientist Would Think, if One Existed

https://www.greenmedinfo.com/blog/op-ed-coron...ne-existed

OP-ED by Jon Rappoport

In a recent article, I explained why the diagnostic test for the coronavirus in a patient is worthless and unreliable. The implications of that fact are enormous.

Here, I want to make further comments on fake science.

A rational researcher, at the CDC, if one existed, would say, upon hearing of a possible outbreak in the city of Wuhan: "Let's see the proof that a new virus is responsible, is the causative agent."

What kind of proof would he be asking for?

First, he would want to know, "Do researchers there have an actual biological specimen of this new virus? Do they have the real thing?"

And if the answer came back yes, he would reply, "We're sending in one of our Wuhan people so he can confirm that."

But how would the confirmation work? You can't just lay a specimen of a virus on a table and shine a light on it. It's far too small to see.

There is a traditional method of observation. It's called an electron microscope photograph (an EM). Certain established procedures exist for obtaining an EM from a patient's tissue sample. The CDC scientist would want to make sure the Chinese scientists had carried out this process correctly.

He would say, "Let's have a look at the Chinese EM." He wants to confirm there are many identical particles of the new virus in the EM. Let's buck the odds and imagine he does confirm it. So far, so good.

But there is more. And here is where the rubber meets the road and the failure factor is very high. I need to back up a bit to explain.

When a clinical trial of a new drug is done (and here I'll make a gigantic leap and assume it's done correctly), is it carried out on one patient?

Is the result of giving the drug to a single patient then extrapolated to mean everyone will react the way this one person did? Of course not. That would be absurd. In a clinical trial, sooner or later, researchers are dealing with a large number of volunteers. A thousand or more.

So, in the case of a new coronavirus, in China, the rational CDC scientist would say: "I want to see electron microscope photographs derived from five hundred patients who have been provisionally diagnosed with the new disease."

I myself ask, where are these photographs? Where are the completely necessary photographs? Because the Chinese scientist would tell his CDC counterpart, "Oh, we didn't carry out the EM procedure on five hundred patients. We carried it out on one. Two. Maybe three. I'm not sure."

At which point, this fantasy rational CDC scientist would blow his stack. He would say, "You're declaring a new epidemic based on two or three photographs from two or three patients??"

Of course, I would need rock solid proof that, at the CDC, there is a rational scientist who would ask for EM pictures from five hundred patients, and explode if he couldn't find them because they were never done. Show me such a rational CDC scientist. Bring him forward. I want to interview him. I want to find out how he feels being ostracized by every other scientist at the CDC.

Consider this likely scenario---which explains why researchers only did the EMs on two or three of the patients. If someone actually performed the electron microscope work on 500 patients diagnosed with the new disease, he would find some indication, in the photographs, of a coronavirus in maybe nine patients.

At which point, in Wuhan, they would shrug and say, "Well, wow, that didn't work out. What a flop. Our hypothesis of a new disease based on a new coronavirus collapsed. We should have been able to see lots of the virus in the photos from ALL 500 patients, or at least the overwhelming percentage of the 500. And we didn't. Back to the drawing board. Let's see. What's the primary sign of the new disease? Pneumonia? Come to think of it, about 300,000 people in China die of pneumonia every year. How about we look at some studies on the air quality here in Wuhan? I think my colleague down the block has a pile of them. Let's walk over there. Anybody have a searchlight so we can see the street through the fog of pollution? Let me get my oxygen tank and breathing helmet."

And that would be the end of that.

Back in Atlanta, the rational CDC scientist would say to his colleagues, "That Chinese outbreak wasn't a virus. How about we spend the afternoon going through some of our own studies on vaccines? I know the fraud is rampant. Let's get it out in the open."

Sure. Happens every day over at the CDC.

Of course, I could be wrong. Maybe someone has done electron microscope photographs derived from 500 patients diagnosed with the new epidemic disease. LET'S SEE THE PHOTOS. SHOW THEM TO ME. We'll have a few non-conflicted experts analyze them.

Otherwise, don't talk about science. There is no science going on.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 22

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 41

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 27

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 32

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 36

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 53

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding National Fuel Gas's Market Dynamics and Trends

Updated Category News Views 128

Analyzing National Fuel Gas's Short Interest Trends National Fuel Gas recently reported a decline in its short percent of float, falling 6.75%. This suggests a change in sentiment among investors towards the company’s future performance. Currently, the company has 2.20 million shares sold short, representing a modest 2.9% of regular shares available for trading. Traders...

Continue Reading
Elisa's AI Solution Fuels the World's Largest Sand Battery

Updated Category News Views 299

The World’s Largest Sand Battery: Optimizing Energy Storage The world's largest Sand Battery, under construction, is positioned to revolutionize energy efficiency. This innovative solution focuses on producing clean district heating, significantly curbing emissions. Optimizing the use of the Sand Battery to adapt to electricity price fluctuations is a key objective....

Continue Reading
Coldwell Banker's Latest Initiative Aims for Your Dream Home

Updated Category News Views 316

Coldwell Banker Real Estate Launches New Campaign Coldwell Banker Real Estate has recently unveiled an exciting new campaign titled 'Live Well With Coldwell.' This initiative is designed to revolutionize the way people search for their dream homes. With a blend of touching storytelling, innovative technology, and a commitment to luxury, this campaign marks a significant...

Continue Reading
Explore Celtic Tours: A Fresh Digital Experience Awaits

Updated Category News Views 158

Exciting Launch of Celtic Tours' New Website Celtic Tours has officially unveiled an impressive new website, opening up a world of touring options that captivate travelers worldwide. With years of experience in the travel industry, Celtic Tours is enhancing customer experiences by providing a user-friendly platform where adventurers can explore various touring options and...

Continue Reading
Influential Leaders Take the Stage at Fortune Global Forum

Updated Category News Views 276

Exciting Lineup for the Fortune Global Forum Upcoming events bring together some of the most impactful minds in global business. The Fortune Global Forum is set to feature a dynamic array of speakers, making it a must-attend for those interested in the intersection of business and global leadership. Highlighting notables in the lineup Among the confirmed speakers is the...

Continue Reading